2022-07-01 14:49:04
Latest Post
IRB Infra's SPV achieves receives Completion Certificate for its Hapur to Moradabad Six Laning Highway Project in Uttar Pradesh
PVP Ventures Ltd enters into agreement with Casagrand Builders for joint development
Wipro updates on sale of preferred stocks of Harte Hanks Inc
CSB Bank Ltd revises interest rates from July 1, 2022
Jubilant HollisterStier to expand its CMO manufacturing facility at Montreal, Canada
Stock Report
Fredun Pharmaceuticals posts net profit of Rs. 2.29 crores in Q4FY22
Posted On : 2022-05-16 19:49:04( TIMEZONE : IST )
Fredun Pharmaceuticals Ltd has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 71.8451 crores during the period ended March 31, 2022 as compared to Rs. 54.2325 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 2.2957 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 1.8716 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 5.18 for the period ended March 31, 2022 as compared to Rs. 4.22 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 71.8451 crs | ₹54.2325 crs |  32.48% |
| Net Profit | ₹2.2957 crs | ₹1.8716 crs | 22.66% |
| EPS | ₹5.18 | ₹4.22 | 22.75% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 71.8451 crores during the period ended March 31, 2022 as compared to Rs.42.3797 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.2.2957 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.0.7271 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.5.18 for the period ended March 31, 2022 as compared to Rs.1.82 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 71.8451 crs | ₹42.3797 crs | 69.53% |
| Net Profit | ₹2.2957 crs | ₹0.7271 crs | 215.73% |
| EPS | ₹5.18 | ₹1.82 | 184.62% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.226.0894 crores during the Financial Year ended March 31, 2022 as compared to Rs.135.2899 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.6.3353 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.2.0146 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.14.29 for the Financial Year ended March 31, 2022 as compared to Rs.5.05 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹226.0894 crs | ₹135.2899 crs | 67.11% |
| Net Profit | ₹6.3353 crs | ₹2.0146 crs | 214.47% |
| EPS | ₹14.29 | ₹5.05 | 182.97% |
Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 948.75 as compared to the previous close of Rs. 909.15. The total number of shares traded during the day was 4284 in over 177 trades.
The stock hit an intraday high of Rs. 954.60 and intraday low of 881.60. The net turnover during the day was Rs. 3986308.00.
